HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cost analysis of unilateral and bilateral pallidotomy for Parkinson's disease.

Abstract
With the rapid increase in provision of deep brain stimulation for Parkinson's disease, the efficacy of pallidotomy in symptom alleviation appears to be increasingly ignored. We demonstrate that lesional surgery is effective with benefit over a significant period of time with very significant societal cost savings. Such studies are essential for future planning of services so that maximum numbers of patients can benefit from surgery, both lesional and neuromodulation, as deemed appropriate.
AuthorsA L Green, C Joint, H Sethi, P Bain, T Z Aziz
JournalJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (J Clin Neurosci) Vol. 11 Issue 8 Pg. 829-34 (Nov 2004) ISSN: 0967-5868 [Print] Scotland
PMID15519857 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antiparkinson Agents
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents (economics, therapeutic use)
  • Cohort Studies
  • Costs and Cost Analysis (methods)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination
  • Pallidotomy (economics, methods)
  • Parkinson Disease (drug therapy, economics, surgery)
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: